leisure time -WSS

leisure time

author：Wikipedia 2025-09-27 19:37:23 - browse：1

Editor’s note: A recording of the event is embedded below.

Now that biosimilar versions of Humira are starting to arrive, what happens next? Will this finally prove the case that biosimilars can deliver on big health care savings? What key signals will indicate how biosimilars might be prescribed, or paid for?

Let’s dive in and discuss what to watch in the months ahead.

Speakers:

Alex Brill, CEO, Matrix Global Advisors
Chris Brown, managing partner and co-founder, Integrity Rx Partners
Fran Gregory, PharmD, vice president of emerging therapies, Cardinal Health
Michael Gonzales, independent health care consultant, Michael Gonzales, LLC; former national and regional account director, AbbVie
Ed Silverman, Pharmalot columnist, senior writer, STAT (moderator)
Thomas Newcomer, head of U.S. market access, Samsung Bioepis (sponsor speaker)

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Average age of first period drops to 11.9 years, study shows

WSS

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Adam's Biotech Scorecard: Do Sarepta's exon

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Apellis safety probe of eye disease drug centers on injection needle

FDA panel gives mixed vote on blood pressure devices

Apellis safety probe of eye disease drug centers on injection needle

explore

leisure time

focus

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Latest bird flu infection made farmworker sicker than earlier cases

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How to make AI work for medicine

Cancer drug shortages should be causing more outrage

Radiation, mainstay of cancer treatment, begins a fade

Psychedelics group wrestles with new pharma identity

Winners, losers from Medicare’s list of drugs subject to price talks

Medicare details structure of new drug price negotiation program

Health insurers say they are turning to AI to cut costs, improve care

hotspot

What do new weight loss drugs mean for bariatric surgery?

Lab trade group sues FDA to halt regulation of lab

NYU Langone launches private ChatGPT for its health care data

Stigma and the return of syphilis

2024 GOP presidential candidates spar over abortion in debate

Study finds new variant for Parkinson’s in African populations

entertainment

hotspot

entertainment

leisure time